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AKR mice show a high incidence of spontaneous lymphomas that are virtually 
all of the T  lymphocyte type and arise predominantly in the thymus (1). Thymus 
removal at the age of 1-3 mo markedly reduces the spontaneous tumor incidence. 
These thymectomized mice develop a  low incidence of extrathymic lymphoid 
tumors, which appear  late in life.  Some lymphomas occurring sporadically in 
peripheral lymphoid tissues of old intact or thymectomized mice were shown to 
have a dual nature, bearing characteristics of both T  and B cells (2, 3). Although 
the thymus has been considered as the primary site of neoplastic transformation 
and proliferation, we have shown previously (4) that premalignant lymphoid cells 
(PLC) were present in fetal liver of 16-d-old AKR embryos, and among bone 
marrow (BM)  cells of intact AKR mice from the age of 14  d  onwards. Thus, 
using the transplantation bioassay method, we showed (4) that bone marrow cells 
from AKR mice of different ages, when transferred into intact irradiated (AKR 
×  DBA/2)F1 recipients, caused T  cell lymphoma development of AKR origin in 
80-100%  of the recipients. In contrast, transplantation tests failed to reveal the 
presence of PLC in the thymus or spleen during the first few months of life (5, 
6).  These findings suggest that the thymus provides a suitable environment for 
the proliferation and differentiation of PLC present  in  BM  since birth.  PLC 
present  in  intact mice have been  shown to differ qualitatively from leukemic 
cells.  They have the characteristics of prothymocytes, and require the thymus 
microenvironment for further proliferation into autonomous leukemic cells (7). 
Since we suggest that the initial site of PLC occurrence is among bone marrow 
cells, they should be present irrespective of presence or absence of the thymus. 
In this study, we tested whether 8-12-mo-old AKR mice thymectomized at 
the age of 40-60  d  were carriers of dormant PLC that could be triggered to 
develop into lymphoid tumors after transplantation of BM cells into the appro- 
priate recipients. The developing lymphomas were screened with various T  and 
B cells conventional and monocionai antibodies (mAb) to define their character- 
istics. 
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Materials and Methods 
Mice.  AKR/J and (AKR/J x DBA/2)F~ mice were obtained from the breeding center 
at The Weizmann Institute of Science, and from The Jackson Laboratory (Bar Harbor, 
ME). 
Monoclonal Antibodies and Antisera.  Mouse  anti-mouse Thy-l.1 (HO-22-1) IgM, anti- 
I-A  k (10-2-16), rat anti-mouse Lyt-1 (53-7.3), and anti-Lyt-2 (53-6.7) were obtained from 
Salk Institute Distribution, San Diego, CA. Mouse anti-mouse MCF (18-5) IgG2b was a 
gift from J. Portis, Rocky Mountain  Laboratories,  MT (8). Rat anti-RA3-6B2 and anti- 
RA3-2C2 were obtained from R. Coffman (DNAX, Research Institute of Molecular and 
Cellular Biology Inc., Palo Alto, CA) (9). Rat anti-mouse Fc receptor (FcR) (IgG1) NEI- 
032 was purchased  from New England Nuclear, Boston, MA. Goat anti-mouse # chain 
(anti-38-C-13 IgM) F(ab)2 was a gift from J. Haimovich, Tel Aviv University, Tel Aviv, 
Israel.  Rabbit  anti-b chain was obtained from I.  Zan-Bar, The Weizmann Institute of 
Science. Goat anti-IgM (heavy and light chains) was purchased from Bio-Yeda, Rehovot, 
Israel.  Anti-TL.4 was  prepared  in  our  laboratory,  as  previously  described  (6). The 
fluorescein  isothiocyanate  (FITC)  conjugates  of anti-mouse IgG (Meloy Laboratories, 
Inc., Springfield, VA), anti-rat IgG, anti-goat IgG, anti-rabbit IgG (Bio-Yeda), and anti- 
mouse Ig (Nordic, Tilburg, The Netherlands) were used for fluorescence labeling. 
lmraunofluorescence and Flow Cytometry (FCM).  Immunofluorescence was performed as 
described  in detail  elsewhere  (6). Fluorescence  was measured by FCM analysis, using 
FACS II (Becton-Dickinson Immunocytochemistry Systems, Mountain View, CA). 
Results 
Identification of  PLC Among BM Cells.  The leukemogenic potential of BM cells 
from thymectomized (when 40-60 d  old) AKR mice, removed at age 250-360 
d, was tested. BM cells were transplanted into intact or thymectomized, irradiated 
(400  rad  whole-body irradiation) or nonirradiated 6-wk-old AKR or  (AKR  X 
DBA/2)F1 mice (presence of thymus and irradiation of the recipient are prereq- 
uisites for the development of PLC derived from 14-d-old AKR mice into T  cell 
lymphoma [7]). Hybrid mice were used as recipients to verify the AKR origin of 
the  developing  tumors  (by  serological  or  transplantation  tests).  The  results 
obtained, summarized in Table I, clearly indicate that each thymectomized AKR 
mouse was a carrier of PLC, since we obtained a  100%  lymphoma incidence of 
AKR origin after BM transplantation. The absence of thymus in the recipients 
and lack of radiation pretreatment did not affect the high incidence of lymphoma 
development in the BM recipients. All the lymphomas developed extrathymically, 
predominantly in the spleen, and in many cases,  also involved lymph node and 
liver dissemination. 
Characteristics  of  Tumors.  The  cell  surface  phenotypes  of  these  obtained 
TABLE  I 
Leukemogenic Potential of BM  from Thymectomized AKR Mice 
Age of  Leukemia inci- 
Exp.  BM do-  Treatment of BM recipients  dence of AKR  Latency 
nors*  origin 
d  d 
30 d  24 h 
24-172-182  300  AKD=Thx*  )  400rad  ,  +BMi.v.  !  11/11  (100%)  140--. 10 
24-516-520  330  AKR Thx  ~ +  BM i.v.  5/5  (100%)  155-  22 
24-666-671  360  AKD~  , +  BM i.v.  5/5  (100%)  35 
20 d  24  h 
25-195-200  250  AKR Thx  ,  400 r  ~ +  BM i.v.  4/5  (80%)  220-+ 12 
* AKR mice were thymectomized  at the age 40 d (Exp. 24-172-182), or 60 d (all other groups). 
* Thx, thymectomized. 
! BM transfer was done from one donor to one recipient; 3-4 x  10 ~ cells injected intravenously (Lv.). PELED  AND  HARAN-GHERA  BRIEF  DEFINITIVE  REPORT  1083 
lymphoid  tumors  were  examined  by  flow  microfluorometry  performed  on  a 
Becton-Dickinson  FACS II.  All  the  25  lymphomas obtained were found to be 
Thy-!-, but were positively stained with anti IgM.  12 out of these 25 lymphomas 
were analyzed more extensively with antibodies that could indicate the T  or B 
cell  attributes  of these  lymphoid  tumors:  anti-Thy-1,  anti-u,  anti-&  RA3-2C2 
(which reacts  with  pre-B and  B  cells,  and  weakly with  peripheral  T  cells [9]), 
RA3-6B2 (reacts only with B cells [9]),  anti-I-A k, and anti-FcR.  We also tested 
the possible expression  of the thymus  leukemia alloantigen,  TL.4,  on  the cell 
surface of these lymphomas, because we had previously found (6) its expression 
on  BM  cells of 1-15-d-old  AKR  mice.  Since anti-Lyt-1  was shown  to  mark  a 
subpopulation of B cells at several different stages of differentiation (10), as well 
as B cell lymphomas (11),  we included it in testing the lymphomas,  mAb  18-5, 
which reacts with the envelope recombinant virus, MCF, (8) (considered to have 
a major role in T  cell leukemia development in AKR mice) was also included in 
the analysis to obtain  preliminary  evidence of the  possible involvement of the 
AKR recombinant virus in the development of these tumors. The results of these 
immunofluorescence  studies  are  summarized  in  Table  II,  and  representative 
fluorescence profiles are shown in Fig.  1. All tumors were Thy-l-, and stained 
with  antibodies  specific  for  B  cells.  The  expression  of Lyt-I  on  these  B  cell 
lymphomas coincides with  similar  observations by other  investigators  (11,  12). 
The most surprising observation was the expression of TL.4 on all tested tumors. 
To  ascertain  that  the  surface  markers  of these  lymphomas  were  integral 
membrane  components  of known  molecular  weight,  the  following tests  were 
performed: lactoperoxidase iodination (13) to scan for cell surface markers, and 
metabolic  labeling  with  [35S]methionine  for  the  biosynthesis  of  the  relevant 
markers. A comparative analysis of a T  and B cell lymphoma derived from AKR 
mice  was  done.  The  lysates  from  the  tumors  were  immunoprecipitated  with 
different  antibodies  and  run  on  sodium  dodecyl  sulfate-polyacrylamide  gel 
electrophoresis, with suitable markers (14). u heavy chain (~68,000 tool wt) was 
immunoprecipitated  from the B cell lymphoma (24-180),  and a  surface glyco- 
protein  of 220,000  mol  wt  was  immunoprecipitated  with  mAb  RA3-2C2,  in 
TABLE  II 
Cell Surface Phenotypes of Lymphoid Tissues Analyzed on FACS II 
Tumor  TL.1  TL.4  Thy-1  #  6  2C2  6B2  I-A  FcR  Lyt-1  Lyt-2  18-5 
24-177  -  +  -  +  -  +  +  ND  ND  ND  ND  ND 
24-178  -  +  -  +  +  +  +  +  +  +  -  + 
24-180  -  +  -  +  +  +  +  -  +  +  -  + 
24-182  -  +  -  +  -  +  +  +  +  +  -  - 
24-516  -  +  --  +  +  +  +  +  ND  ND  ND  ND 
24-666  -  +  --  +  -  +  ÷  +  +  +  -  - 
24-667  -  +  -  +  -  +  +  -  •  +  +  -  - 
24-668  -  +  -  +  +  +  +  +  ND  +  -  - 
24-669  -  +  -  +  +  +  +  +  ND  +  -  + 
24-671  -  +  -  +  -  +  +  -  +  ND  -  - 
25-195  ND  -+  -  +  -  +  +  +  ND  ND  ND  ND 
25-197  ND  --.  -  +  +  +  +  +  +  +  -  ND 
The  following  antibodies  were  used:  monoclonal  anti-Thy-1.1  (clone  HO-22.1),  anti-TL.  1  (clone  65/26),  anti-Lyt- 
~  12  k  1  (clone  53-7.3);  anti-Lyt-2  (53.6-7)~  RA3-2C2  ,  RA3-6B2  ,  anti-FcR  (NE1-032),  anti-MCF  (18-5)  ,  and  anti-IA 
(clone  10-2-16);  polyclonal  anti-TL.4  l°, goat  anti-#  (antl-38-C-13  IgM)  F(ab')~,  and  rabbit  anti-&  For  staining,  the 
relevant  FITC  conjugates  were  used:  goat  anti-mouse  lg,  goat  anti-mouse  IgG,  goat  anti-rabbit  IgG,  rabbit  anti- 
rat  lgG,  and  rabbit  anti-goat  lgG.  (+)  indicates  ~>40%  positive  cells, with  relative  fluorescence  intensity  of  >-100 
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RELATIVE  FLUORESCENCE INTENSITY 
FIGURE  1.  Immunofluorescence was performed as described in detail elsewhere (6).  FACS 
II fluorescence  intensity profiles of B  cell leukemia 24-180  reacted  with mouse anti-mouse, 
anti-TL.4, anti-I-Ek/C  k (clone 14-4-4),  anti-I-A k (clone  10-2-16),  anti-Thy- 1. t (clone Ho-22-1 ), 
rat anti-mouse FcR (NEI-032), RA3-6B2, rabbit anti-mouse 6 chain, and goat anti-mouse # 
chain, then stained with the relevant FITC conjugate of goat anti-mouse Ig, rabbit anti-rat 
IgG, rabbit anti-goat  IgG, and goat anti-rabbit IgG. BG means background when cells were 
stained with the second antibody only. 
contrast to the T  cell lymphoma being negative for both markers. The synthesis 
of different glycoproteins by a B cell lymphoma and not by the T  cell lymphoma 
tested  was  demonstrated  by  immunoprecipitation  with  anti-IgM  and  anti-I-A. 
TL.4  was  common  for  both  T  and  B  iymphomas.  The  anti-IgM  antiserum 
specifically  immunoprecipitated  a  single  light chain  (~20,000  mol wt) and two 
heavy  chains  that  correspond  to the  cytoplasmic  (~69,000  tool wt)  and  mem- 
brana] (75,000 mo] wt) chains. Anti-TL.4 precipitated a glycoprotein of ~48,000 
and anti-I-A k precipitated  two chains,  a  and/3, of ~30,000  tool wt, and a third 
band, probably the invariant chain. 
Discussion 
Herein,  we show the capacity  of PLC harbored  in  250-360-d-old  thymecto- 
mized  AKR  mice  to  induce  a  high  incidence  of B  cell  lymphomas after  their 
transfer into appropriate recipients  (4).  A  high incidence  of T  cell  lymphomas 
was obtained when PLC from intact AKR mice of similar age were transplanted 
into the appropriate recipients.  Thus, regulatory signals provided by the intact 
thymus of AKR mice influence the direction of differentiation of the preleukemic 
pluripotent stem cells.  In previous studies (6) we showed an inverse age-related 
expression of TL.4 on T  cell lymphomas, the maximal level (58% TL.4 + tumors) 
in  lymphomas developing  in  5-6-mo-old AKR  mice.  Exposure of young AKR PELED  AND  HARAN-GHERA  BRIEF  DEFINITIVE  REPORT  1085 
mice  to  X-rays  rendered  most  developing  T  cell  lymphomas  TL.4 ÷ (6).  Our 
present findings of TL.4 ÷ B cell lymphomas suggest that a common progenitor 
TL.4 + cell  (pluripotential  stem cell sharing  pre-T and  pre-B properties) could 
serve as a precursor for both T  and B cell lymphomas of AKR origin. The fact 
that all  B cell lymphomas tested expressed Lyt-1 and TL.4 antigens, previously 
believed to be confined to T  cells, may also suggest a common T-B cell differ- 
entiation  pathway.  These results  may confirm  the observations (15) that  adult 
BM contains a  population of pluripotent stem cells that can give rise to both B 
and T  lymphocytes. 
The involvement of MCF in the development of the B cell neoplasms tested is 
doubtful, since cells stained with  18-5 were observed only in three out of eight 
tumors tested (Table II). The possible contribution of ecotropic murine leukemia 
virus (MuLV)  to  B  cell  lymphoma  development  has  been  suggested in  recent 
studies by Fredrickson et al. (16). The inbred Swiss strain,  NFS, which lacks the 
genetic information for ecotropic MuLV develops a low incidence of nonthymic 
lymphomas at the age of 12-18  mo.  Insertion  of AKR viral genes (Akv-1  and 
Akv-2) on  NFS background  (resulting  in  NFS-V congenic  mice  for  ecotropic 
MuLV  induction  loci) rendered  them  more  susceptible (23.8%  lymphomas  in 
NFS-V congenic  mice vs.  7%  in  NFS mice)  to the  development of nonthymic 
iymphomas of B cell phenotype (16). 
Summary 
AKR mice, 6-12  mo after birth,  display a  high  incidence of spontaneous T 
cell lymphomas that can be prevented by thymus removal at the age of 1-3 mo. 
We report here the presence of dormant preleukemic cells among bone marrow 
cells of 8-12-too-old AKR mice that  have been thymectomized when 40-60  d 
old.  Transplantation  of bone  marrow  cells  from  these  thymectomized  AKR 
donors  into  syngeneic  or  hybrid  (AKR  X  DBA/2)F1  intact  or  thymectomized 
recipients resulted in lymphoma development of AKR origin in 80-100% of the 
recipients.  Analysis,  by  flow  microfluorometry,  of the  antigenic  cell  surface 
phenotypes of the developing lymphomas revealed that  all tumors were B cell 
lymphomas, since the cells stained with class-specific anti-IgM reagents and other 
reagents specific for B cells (RA3-2C2, RA3-6B2, anti-I-A, and anti-Fc receptor), 
and were Thy-1-. All these B cell tumors also expressed two T cell differentiation 
antigens,  TL.4,  found  exclusively  on  T  cell  lymphomas,  and  Lyt-1  antigen, 
previously shown  (11) to be expressed on some B cell neoplasms.  The  surface 
markers  ~,  I-A,  RA3-2C2,  and  TL.4  identified  by immunofluorescence,  were 
shown  to  be  integral  membrane  components  synthesized  by the  tumor  cells, 
rather than passively acquired proteins. 
Received for publication  9 April 1985 and in revised form 4 June 1985. 
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